Rare Disease Trial, Recruiting (NCT05007990)

Rare Disease Trial, Recruiting NCT05007990 Sponsor: National Human Genome Research Institute (NHGRI) Condition: Rare Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05007990 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rare Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older.
People who currently consider themselves the main caregiver for someone living with a long-term medical condition, OR people who were the main caregiver for someone who has since passed away, OR people who have been identified by another participant as part of a caregiving support network.
People who are able to give their own consent to take part in research.
People who can read, understand, and speak English well enough to complete interviews, surveys, and consent forms.
People who are physically able to take part in the assessments involved in the study.

Who may not be able to join:

The person receiving care (the individual with the chronic medical condition) is not eligible to participate.
Staff members employed at the NHGRI (the institute running this study) are not eligible to participate.
People who have difficulty with thinking, understanding, or decision-making that would prevent them from giving their own consent to participate are not eligible to enroll.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Laura M Koehly, Ph.D., National Human Genome Research Institute (NHGRI)

Phone: (301) 451-3999

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05007990

Sponsor: National Human Genome Research Institute (NHGRI)

Phase: Not Applicable

Status: Recruiting

Condition: Rare Disease

Trial contact: (301) 451-3999

More information: https://clinicaltrials.gov/study/NCT05007990

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older.
People who currently consider themselves the main caregiver for someone living with a long-term medical condition, OR people who were the main caregiver for someone who has since passed away, OR people who have been identified by another participant as part of a caregiving support network.
People who are able to give their own consent to take part in research.
People who can read, understand, and speak English well enough to complete interviews, surveys, and consent forms.
People who are physically able to take part in the assessments involved in the study.

Who may not be able to join:

The person receiving care (the individual with the chronic medical condition) is not eligible to participate.
Staff members employed at the NHGRI (the institute running this study) are not eligible to participate.
People who have difficulty with thinking, understanding, or decision-making that would prevent them from giving their own consent to participate are not eligible to enroll.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Human Genome Research Institute (NHGRI)

Registry

ClinicalTrials.gov

Start date

8 September 2022

Est. completion

31 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Natural History

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov